Author Correction: NIPBL-mediated RAD21 facilitates tumorigenicity by the PI3K pathway in non-small-cell lung cancer

• Xiaoling Xu,
• Ding Wang,
• Weizhen Xu,
• Huihui Li,
• Ning Chen,
• Na Li,
• Qifeng Yao,
• Wei Chen,
• Jianxiang Zhong,
• Weimin Mao

Affiliations

Xiaoling Xu

Department of Radiation Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine

Ding Wang

Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Zhejiang Cancer Research Institute

Weizhen Xu

Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Zhejiang Cancer Research Institute

Huihui Li

Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Zhejiang Cancer Research Institute

Ning Chen

The Second Clinical Medical College of Zhejiang Chinese Medical University

Na Li

The Second Clinical Medical College of Wenzhou Medical University

Qifeng Yao

The Second Clinical Medical College of Wenzhou Medical University

Wei Chen

Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Zhejiang Cancer Research Institute

Jianxiang Zhong

School of Life Science and Technology, Southeast University

Weimin Mao

Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer, Zhejiang Cancer Research Institute